NCT05634187 (ENTGI-reflux) is a clinical trial of Functional endoscopy in Reflux Disease, sponsored by University Hospital Muenster.

Who is sponsoring NCT05634187?

NCT05634187 is sponsored by University Hospital Muenster.

What drugs are being tested in NCT05634187?

Interventions in NCT05634187: Functional endoscopy.

What condition does NCT05634187 study?

NCT05634187 studies Reflux Disease, Reflux, Gastroesophageal, Reflux, Laryngopharyngeal.

Is NCT05634187 still recruiting?

NCT05634187 is currently completed. Last updated 15 April 2024.

Last reviewed 2024-04-15 · How we verify

NCT05634187: ENTGI-reflux

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features

Completed Last updated 15 April 2024

What this trial tests

trial testing Functional endoscopy in Reflux Disease in 190 participants. Completed in 23 January 2024.

Timeline

20 November 2022

Primary endpoint
23 January 2024

23 January 2024

Quick facts

Lead sponsor	University Hospital Muenster
Status	Completed
Study type	OBSERVATIONAL
Enrollment	190
Start date	20 November 2022
Primary completion	23 January 2024
Estimated completion	23 January 2024
Sites	1 location across Germany

Drugs / interventions tested

Functional endoscopy

Conditions studied

Reflux Disease — all drugs for Reflux Disease →
Reflux, Gastroesophageal — all drugs for Reflux, Gastroesophageal →
Reflux, Laryngopharyngeal — all drugs for Reflux, Laryngopharyngeal →

Sponsor

University Hospital Muenster

Who can join

18 and older, any sex, with Reflux Disease or Reflux, Gastroesophageal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients suffering from gastroesophageal reflux may suffer from both esophageal and laryngeal irritations. The investigators developed an endoscopic technique called functional endoscopy to evaluate alterations in the larynx and pharynx as well as in the esophagus simultaneously as one-stop-shop.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Reflux Disease

Currently open trials in the same condition.

NCT06129474 — Deprescribing Inappropriate Proton Pump Inhibitors · NA · recruiting

Other University Hospital Muenster trials

Trials by the same sponsor.

NCT07414498 — MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery · NA · not yet recruiting
NCT06999174 — Multiparametric MRI for Characterization of Hepatocellular Carcinoma · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting
NCT06648733 — Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care · NA · recruiting
NCT06464302 — Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized R · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05634187 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Muenster
Last refreshed: 15 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05634187.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing